A landmark nationwide study of 51.6 million South Koreans has reignited fierce debate about the long-term effects of repeated COVID-19 mRNA vaccinations. Published in November 2025 in the International Journal of Infectious Diseases, the research reveals a complex, dose-dependent pattern: more vaccine doses correlate with significantly higher rates of common colds and upper respiratory infections (URI) in the post-pandemic era — yet lower rates of influenza-like illness (ILI) and pertussis. Critics call it evidence of “VAIDS” (Vaccine-Acquired Immune Deficiency Syndrome). Defenders call it statistical noise from lockdowns, age differences, and rebound effects. Here is the unfiltered analysis — facts, numbers, logic, and both sides of the argument — so you can decide.
The Study: What the Data Actually Shows
Using South Korea’s national health insurance database linked to vaccination records, researchers from Korea University and Seoul National University analyzed the entire population (N = 51,645,564; analytic cohort ~39.4 million after exclusions). They compared post-pandemic respiratory infection rates (2023–2024) against pre-pandemic baselines (2017–2019) and examined risks by number of COVID-19 vaccine doses received by June 2023.
Key post-pandemic trends:
- Upper respiratory tract infections (URI) and common colds resurged sharply — common cold incidence ~2.2 times higher than pre-pandemic forecasts.
- Pertussis exploded 46-fold above expected levels in late 2023.
- ILI and pneumonia remained suppressed initially but showed mixed patterns later.
“Individuals (≥4th dose) had lower risks of ILI (adjusted hazard ratio: 0.55 [95% CI: 0.54-0.57]) and pertussis (0.06 [0.04-0.08]), but higher risks of URI (1.32 [1.32-1.33]) and common cold (1.63 [1.62-1.64]), compared with unvaccinated or partially vaccinated.” — Song et al., International Journal of Infectious Diseases, Nov 2025
In children and adolescents (0–19 years) the signal was strongest. Subgroup analyses (detailed in supplementary data referenced across secondary reports) showed adjusted hazard ratios for common cold climbing dramatically with dose count: up to aHR 6.59 (a 559% increase) for those with 4+ doses versus the reference group (no or 1st dose only). URI risks also rose sharply (aHR up to ~1.83 in youth). Pneumonia showed protective effects in some pediatric and elderly strata with high doses, but the overall pattern for everyday “nuisance” infections pointed upward with more boosters.
A BOMBSHELL study of an ENTIRE COUNTRY (n=51 MILLION) confirms COVID shots induced VAIDS in EVERY age group.Vaccinated Koreans suffered a dose-dependent rise in the common cold, infections, pneumonia, and tuberculosis — up to +559%.BILL GATES spent over $100 MILLION on mRNA. pic.twitter.com/RNUMgAah1a— Nicolas Hulscher, MPH (@NicHulscher) May 12, 2026
The VAIDS Interpretation: Critics’ Case
Independent researchers and physicians such as Nicolas Hulscher (McCullough Foundation) argue this is the clearest population-level signal yet of immune dysregulation. They point to:
- Dose-response relationship — the more doses, the higher the risk for common cold/URI.
- Age-independent signal persisting across every group examined.
- Possible biological mechanisms discussed in the broader literature: IgG4 class switching (which dampens antiviral responses), innate immune exhaustion from repeated spike-protein exposure, and a shift away from broad mucosal immunity.
They note South Korea had one of the world’s highest vaccination rates (>129 million doses), making “confounder” excuses harder to sustain. The study’s own authors acknowledge “shifts in population-level immunity” and call for “adaptive public health strategies.” Critics say this is as close as peer-reviewed science gets to confirming what they have warned about for years: repeated mRNA instructions may trade narrow protection against severe COVID/ILI for broader vulnerability to everyday pathogens.
The Official and Mainstream Counter-View
Fact-checkers and public-health authorities (Science Feedback, TechARP, etc.) emphasize important caveats the sensational headlines often omit:
- Age confounding: People with 4+ doses were disproportionately older (mean age 67 vs. 37 in low-dose group), and older adults naturally have different infection patterns.
- Post-lockdown rebound: After years of masks, distancing, and school closures, populations lost natural exposure to common viruses — leading to a “catch-up” surge that hit vaccinated and unvaccinated differently due to behavior and testing differences.
- Protective trade-off: The same high-dose group enjoyed markedly lower ILI and pertussis — exactly what vaccines are supposed to do for certain pathogens.
- The study is observational; it cannot prove causation. No mention of “VAIDS” (a non-medical term) appears in the paper itself.
They argue the net public-health benefit of the vaccines (preventing severe COVID) still outweighs these signals, especially when adjusted models are scrutinized.
Latest Development (May 2026)
As of May 12–13 2026 the study has gone viral again on alternative platforms, with renewed claims of “VAIDS across every age group.” No new peer-reviewed follow-up has emerged in the past six months, but the conversation has shifted to real-world excess respiratory illness reports in highly vaccinated nations. South Korean health authorities continue to recommend updated COVID shots for high-risk groups while monitoring post-pandemic immunity shifts. For context on how public health narratives evolve around novel pathogens, see this parallel report on hantavirus monitoring in the US.
Broader Context and Uncomfortable Questions
The South Korean dataset is uniquely powerful — near-universal coverage, minimal selection bias, and objective claims data. Yet the results are nuanced: protection against some threats, apparent vulnerability to others. This mirrors earlier concerns about mRNA platforms potentially altering immune balance (IgG4 shift, original antigenic sin). At the same time, billions of doses were administered during a genuine pandemic, saving lives in the acute phase.
Logical bottom line: Correlation is not causation, but a clear dose-response signal in the world’s largest single-country cohort demands rigorous follow-up — not dismissal. Natural immunity, vitamin D optimization, exercise, and terrain-based health remain relevant comparators, as the study indirectly highlights the limits of narrow vaccine-focused strategies.
Original Source & Full Study
Primary study (open access): Song et al., “Incidence of respiratory infections after the COVID-19 pandemic (2023-2024) and its association of vaccination among entire populations in Korea,” International Journal of Infectious Diseases, 7 November 2025
Original sensational article that triggered current wave: “BOMBSHELL: South Korea Study of 51 Million Confirms COVID Shots Induced VAIDS Across EVERY Age Group,” The People’s Voice, published ~12 May 2026 (the text you provided is based on this piece and Nicolas Hulscher’s X summary).
Emerging Infections & Public Health | Hantavirus & Respiratory Threats